Global Extracorporeal Membrane Oxygenation Machine Market Is Predicted To Grow Around US$ 1,280.4 Million By 2030

April 2023 | Report Format: Electronic (PDF)

The increasing prevalence of cardiopulmonary illnesses and respiratory difficulties is the main factor driving the market. Cardiovascular disease claims one American life every 37 seconds, according to the Centers for Disease Control and Prevention (CDC). Furthermore, among the top 10 causes of death in the United States in 2018 was chronic obstructive pulmonary disease (COPD). Extracorporeal membrane oxygenation (ECMO) is being used more frequently, which has accelerated the development of these systems' technology. The development includes the introduction of oxygenators, hollow pumps, and heparin-coated cannulas utilized in a variety of surgical applications.

The utilization of ECMO machines is driving technological advancements in the field. The latest breakthroughs in surgical technology include the introduction of oxygenators, compact pumps, and cannulas with heparin coatings. Furthermore, the size of newly designed ECMO machines has shrunk, making them more portable and versatile. Portable adapters and miniaturized ECMO machine circuits have also helped in transporting critically ill patients.

During the projected period, the extracorporeal membrane oxygenation market in Asia-Pacific is anticipated to develop at the quickest rate. The increase in healthcare spending by the government and private organizations to develop healthcare facilities is one of the main reasons fueling the expansion of this region. The expansion of the market is also anticipated to be aided by the economic development of nations like Japan, India, and China, as well as growing government attempts to improve healthcare infrastructure and reimbursement practices.

Request a Free Sample Copy: Extracorporeal Membrane Oxygenation Machine Market Report

Extracorporeal Membrane Oxygenation Machine Market Report Highlights

• In July 2021, Xenios AG(Germany) received approval from the National Medical Products Administration (NMPA) in China for the Xenios Console and patient kits for ECMO therapy.
• In February 2020, Fresenius Medical Care AG & Co. KGaA (Germany) received US FDA clearance for Novalung, a heart and lung support system for the treatment of acute respiratory or cardiopulmonary failure.

EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Extracorporeal Membrane Oxygenation Machine Component Outlook (Revenue, USD Million, 2017 - 2030)

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

Extracorporeal Membrane Oxygenation Machine Modality Outlook (Revenue, USD Million, 2017 - 2030)

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

Extracorporeal Membrane Oxygenation Machine Appication Outlook (Revenue, USD Million, 2017 - 2030)

• Respiratory
• Neonates
• Pediatric
• Adult

Extracorporeal Membrane Oxygenation Machine Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America (U.S., and Canada)
• Europe (Germany, U.K., France, Italy, Spain etc.)
• Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
• South America (Brazil, Mexico, Argentina etc.)
• Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

List of Key Players- Extracorporeal Membrane Oxygenation Machine Market

• Medtronic plc
• Sorin Group
• Terumo Cardiovascular Systems Corporation
• MAQUET Holding B.V. & Co. KG
• Medos Medizintechnik AG
• Nipro Medical Corporation
• Microport Scientific Corporation
• Fresenius Medical care AG & Co. KGaA
• Xenios AG

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

76 Kennington Road,

London SE11 6NL,

United Kingdom

USA Phone: +1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/